about
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Adv...
Read More
1.90
0.09
(4.97%)
854.8K
XNAS Volume
XNAS 16 Jan, 2026 4:30 PM (EST)
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution
View Similar
Embed DVM
Neuronetics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..